Showing results (131-140 of 505) with videos related to
Sort By:
Pageof 51
Current Topics in Medicinal Chemistry|May 25, 2006
The NMDA/D1 receptor complex as a new target in drug developmentCristina Missale, Chiara Fiorentini, Chiara Busi, et al.Current Medical Research and Opinion|July 5, 2003
Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitorsA Bianchetti, R Rozzini, M TrabucchiJournal of Anatomy|December 1, 1978
The development of the rods in the tapetal cells of the catM L Lucchi, E Callegari, R BortolamiScience (New York, N.Y.)|November 22, 1996
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activationM Grilli, M Pizzi, M Memo, et al.European Journal of Pharmacology|March 14, 1995
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetamM Pizzi, O Consolandi, M Memo, et al.Brain Research. Molecular Brain Research|March 1, 1992
Rat pituitary cells selectively express mRNA encoding the short isoform of the y2 GABAA receptor subunitA Valerio, C Tinti, P Spano, et al.The Journal of Biological Chemistry|June 21, 1996
Interleukin-1beta and glutamate activate the NF-kappaB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal culturesM Grilli, F Goffi, M Memo, et al.The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptorsC Missale, M Memo, P Liberini, et al.Neuropharmacology|March 1, 1985
Tolerance to some behavioural effects of lisuride, a dopamine receptor agonist, and reverse tolerance to others, after repeated administrationM O Carruba, S Ricciardi, E Chiesara, et al.Drugs|January 1, 1987
Microcirculation and neurotransmitter metabolism in the pathophysiology of brain ischaemia. A role for calciumM S Magnoni, S Govoni, M TrabucchiPageof 51